Assessing Risk in Patients With Pulmonary Arterial Hypertension

For patients with pulmonary arterial hypertension (PAH), comprehensive risk assessment helps determine patient prognosis, monitor disease progression, and inform treatment decisions. If widely adopted, risk assessment can help optimize care and may improve mortality risk in patients with PAH.
This webinar features an in-depth discussion on PAH risk assessment, including the latest clinical guideline recommendations and evidence-based tools like REVEAL 2.0 and REVEAL Lite 2, which can help physicians accurately assess patient risk.
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.